ATE327770T1 - Zellulosepartikel für eine pharmazeutische zusammensetzung - Google Patents

Zellulosepartikel für eine pharmazeutische zusammensetzung

Info

Publication number
ATE327770T1
ATE327770T1 AT01979030T AT01979030T ATE327770T1 AT E327770 T1 ATE327770 T1 AT E327770T1 AT 01979030 T AT01979030 T AT 01979030T AT 01979030 T AT01979030 T AT 01979030T AT E327770 T1 ATE327770 T1 AT E327770T1
Authority
AT
Austria
Prior art keywords
cellulose particles
pharmaceutical composition
less
cellulose
pharmaceutical
Prior art date
Application number
AT01979030T
Other languages
English (en)
Inventor
Shun Ichi Gomi
Etsuo Kamada
Yuuji Hirano
Original Assignee
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind filed Critical Asahi Chemical Ind
Application granted granted Critical
Publication of ATE327770T1 publication Critical patent/ATE327770T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/12—Powdering or granulating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B16/00—Regeneration of cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2301/02—Cellulose; Modified cellulose

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
AT01979030T 2000-11-06 2001-11-06 Zellulosepartikel für eine pharmazeutische zusammensetzung ATE327770T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000338243 2000-11-06

Publications (1)

Publication Number Publication Date
ATE327770T1 true ATE327770T1 (de) 2006-06-15

Family

ID=18813481

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01979030T ATE327770T1 (de) 2000-11-06 2001-11-06 Zellulosepartikel für eine pharmazeutische zusammensetzung

Country Status (12)

Country Link
US (1) US20040043964A1 (de)
EP (1) EP1338288B1 (de)
JP (1) JP4062436B2 (de)
KR (1) KR100526285B1 (de)
CN (1) CN1222318C (de)
AT (1) ATE327770T1 (de)
AU (2) AU2002211018B2 (de)
BR (1) BR0115058A (de)
CA (1) CA2427991C (de)
DE (1) DE60120211T2 (de)
TW (1) TWI290471B (de)
WO (1) WO2002036168A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4737754B2 (ja) 2003-05-30 2011-08-03 旭化成ケミカルズ株式会社 セルロース粉末
JP4969104B2 (ja) 2004-01-30 2012-07-04 旭化成ケミカルズ株式会社 多孔質セルロース凝集体及びその成型体組成物
TWI313278B (en) 2005-04-22 2009-08-11 Asahi Kasei Chemicals Corp Porous cellulose agglomerate and molded composition thereof
WO2008005848A2 (en) * 2006-06-30 2008-01-10 Novavision, Inc. Diagnostic and therapeutic system for eccentric viewing
WO2008010524A1 (en) * 2006-07-19 2008-01-24 Asahi Kasei Chemicals Corporation Process for producing spherical elementary granule containing readily water-soluble drug
US20090196934A1 (en) * 2006-07-26 2009-08-06 Asahi Kasei Chemicals Corporation Spherical elementary granule and method for production thereof
WO2008112565A2 (en) * 2007-03-09 2008-09-18 Anthony Manganaro Method and composition for treating cancer
US8298585B2 (en) 2007-06-06 2012-10-30 Asahi Kasei Chemicals Corporation Cellulose-based fine core particle and process for producing the same
US20100055180A1 (en) * 2007-10-10 2010-03-04 Mallinckrodt Baker, Inc. Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
SG185257A1 (en) * 2007-10-10 2012-11-29 Avantor Performance Mat Inc Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof
JP2009155215A (ja) * 2007-12-25 2009-07-16 Freunt Ind Co Ltd 球形粒及びその製造方法並びに放出制御製剤の製造方法
JP2009263303A (ja) * 2008-04-28 2009-11-12 Freunt Ind Co Ltd 球形顆粒及びその製造方法
WO2009142255A1 (ja) * 2008-05-21 2009-11-26 旭化成ケミカルズ株式会社 偏析防止効果に優れるセルロース粉末及びその組成物
EP2308483A4 (de) 2008-07-01 2014-09-10 Sawai Seiyaku Kk Verfahren für die herstellung von kugelförmigen mikropartikeln mit tamsulosinhydrochlorid
AU2009316812A1 (en) * 2008-11-19 2011-07-07 Avantor Performance Materials, Inc. Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof
WO2011049203A1 (ja) 2009-10-22 2011-04-28 旭化成ケミカルズ株式会社 メタクリル系樹脂、その成形体及びメタクリル系樹脂の製造方法
JP2011207851A (ja) * 2010-03-30 2011-10-20 Asahi Kasei Chemicals Corp 膨潤性の球状核
UA111162C2 (uk) 2010-08-04 2016-04-11 Флекшен Терап'Ютікс, Інк. Ін'єкційна композиція ацетоніду триамцинолону для лікування болю
ES2642312T3 (es) * 2011-08-04 2017-11-16 Flexion Therapeutics, Inc. Corticosteroides para el tratamiento del dolor de articulaciones
US20160289393A1 (en) * 2013-12-04 2016-10-06 Dow Global Technologies Llc Process for prepring a mixture of a cellulose derivative and a liquid diluent
JP6216074B2 (ja) * 2014-08-12 2017-10-18 旭化成株式会社 微小セルロース粉末
JP5877889B2 (ja) * 2014-11-07 2016-03-08 旭化成ケミカルズ株式会社 膨潤性の球状核
SG11201804530TA (en) * 2015-11-30 2018-06-28 Growth Partners Limited Agent for decreasing fluidity of solid-liquid mixture, and method for producing low-fluidity mixture
JP6366794B2 (ja) * 2016-07-28 2018-08-01 大原薬品工業株式会社 原薬の化学的安定性や服用感を向上した、口腔内崩壊錠
GB201715387D0 (en) * 2017-09-22 2017-11-08 Cambridge Entpr Ltd Treatment of polymer particles
AU2019311268B2 (en) * 2018-07-27 2025-01-16 Chiesi Farmaceutici S.P.A. Novel carrier particles for dry powder formulations for inhalation
JP7199871B2 (ja) * 2018-08-10 2023-01-06 日揮触媒化成株式会社 多孔質セルロース粒子とその製造方法、および洗浄用化粧料
JP7265331B2 (ja) * 2018-09-28 2023-04-26 日揮触媒化成株式会社 多孔質セルロース粒子および化粧料
EP3904429A4 (de) * 2018-12-27 2022-02-23 Asahi Kasei Kabushiki Kaisha Cellulosepulver, seine verwendung und tablette
JP7149885B2 (ja) * 2019-03-22 2022-10-07 株式会社ダイセル セルロース誘導体粒子、化粧品組成物及びセルロース誘導体粒子の製造方法
BR112021021232A2 (pt) * 2019-04-25 2021-12-21 Fuji Pharma Co Ltd Preparação farmacêutica na forma de grânulos, preparação, método de produção de uma preparação farmacêutica e métodos para a produção de comprimidos e para a produção de cápsulas
PH12021553026A1 (en) 2019-07-05 2023-08-23 Swedish Match North Europe Ab An oral pouched nicotine product including a filling material comprising nicotine-containing particles
PL4061155T3 (pl) 2019-11-20 2024-01-29 Swedish Match North Europe Ab Doustny produkt nikotynowy w saszetce, zawierający materiał wypełniający zawierający cząstki nikotyny
JP2021095470A (ja) * 2019-12-16 2021-06-24 王子ホールディングス株式会社 粉末状セルロース
CN113480669B (zh) * 2021-07-13 2022-08-12 安徽山河药用辅料股份有限公司 一种低松密度交联羧甲纤维素钠的制备方法
CN117122069A (zh) * 2022-05-19 2023-11-28 仙乐健康科技股份有限公司 一种颗粒和包含所述颗粒的酸性食品
JP2024110729A (ja) * 2023-02-03 2024-08-16 富士フイルムビジネスイノベーション株式会社 セルロース粒子
JP2024110728A (ja) * 2023-02-03 2024-08-16 富士フイルムビジネスイノベーション株式会社 セルロース粒子
CN117686671B (zh) * 2023-12-11 2024-09-13 国药集团容生制药有限公司 一种优化恩格列净片剂溶出曲线及体内生物等效性的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU508480B2 (en) * 1977-04-13 1980-03-20 Asahi Kasei Kogyo Kabushiki Kaisha Microcrystalline cellulose excipient and pharmaceutical composition containing thesame
JP2976116B2 (ja) * 1989-09-27 1999-11-10 旭化成工業株式会社 球状セルロース粒子の製造方法
EP0452862B1 (de) * 1990-04-18 1995-07-19 Asahi Kasei Kogyo Kabushiki Kaisha Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung
US5322702A (en) * 1992-06-15 1994-06-21 Fmc Corporation Microgranular protein opacifying material
US5417984A (en) * 1992-12-14 1995-05-23 Biocontrol, Inc. Low crystallinity cellulose excipients
CN1296387C (zh) * 2000-07-05 2007-01-24 旭化成株式会社 纤维素粉末

Also Published As

Publication number Publication date
CA2427991C (en) 2008-01-22
DE60120211D1 (de) 2006-07-06
WO2002036168A1 (en) 2002-05-10
JPWO2002036168A1 (ja) 2004-03-18
CN1473054A (zh) 2004-02-04
EP1338288A1 (de) 2003-08-27
EP1338288B1 (de) 2006-05-31
KR100526285B1 (ko) 2005-11-08
AU2002211018B2 (en) 2004-08-05
CN1222318C (zh) 2005-10-12
KR20030051773A (ko) 2003-06-25
CA2427991A1 (en) 2003-05-05
US20040043964A1 (en) 2004-03-04
DE60120211T2 (de) 2007-04-12
TWI290471B (en) 2007-12-01
JP4062436B2 (ja) 2008-03-19
BR0115058A (pt) 2003-10-28
EP1338288A4 (de) 2004-12-29
AU1101802A (en) 2002-05-15

Similar Documents

Publication Publication Date Title
ATE327770T1 (de) Zellulosepartikel für eine pharmazeutische zusammensetzung
ATE270097T1 (de) Partikulärer wirkstoffträger für die pulmonale applikation
BRPI0518310A2 (pt) materiais em partÍculas de alumina transitàrias tendo morfologia e processamento controlados para a formaÇço dos mesmos
MXPA01003255A (es) Manitol pulverulento y su procedimiento de preparacion.
MXPA99009542A (de)
HRP20000434B1 (en) Celecoxib compositions
MXPA04002540A (es) Material impermeable que comprende particulas metalicas nanodimensionadas.
ATE208607T1 (de) Granuläre zusammenzetzungen
ATE364381T1 (de) Formulierungen zur verwendung in inhalationsvorrichtungen
DE69915650D1 (de) Granuläre zusammensetzungen
NO20001794D0 (no) Fremgangsmåte ved fremstilling av partikkelformig polymer
BR9713539A (pt) Composições de tratamento de solos, seu processo de prepararo e sua utilização.
MX2008001645A (es) Composiciones de fexofendina en suspension farmaceutica oral.
BG104596A (en) Pahrmaceutical compositions containing micronized bicyclic drugs
CA2033418A1 (en) Pharmaceutical preparation for oral administration in fluid form
ATE357217T1 (de) Pharmazeutische zusammensetzung enthaltend lamotrigine-partikel mit definierter morphologie
WO2006034397A3 (en) Coating composition
AU2002314972A1 (en) Compressible guaifenesin compositions and method for producing them
EP0665265A3 (de) Zusammensetzungen, enthaltend Metallpartikel im Nanometergrössenbereich.
ATE245974T1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung
NZ521966A (en) Coating composition having thermal properties
ATE260887T1 (de) Kompaktes 2,2-dibrom-3-nitrilo-propionamid
BG104133A (bg) Метод за получаване на невирапин хемихидрат и фармацевтичен състав, който го съдържа
BR9909450A (pt) Pelotas para o uso como um material de redução em processos metalúrgicos de redução para a produção de metais e ligas
UY26653A1 (es) Producto sólido blando estable y eficaz

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties